Aaron Boster, MD, is a multiple sclerosis (MS) neurologist and founder of the Boster Center for Multiple Sclerosis in Columbus, Ohio. He outlines five reasons to discuss changing MS treatment, including relapses, MRI changes, and safety.
Transcript
I think a lot of the success of the relationship between a doctor and a patient, and the decision to make change, is really setting expectations.
So in my mind, there are five reasons why we should have a discussion about potentially changing a medicine.
Number one, if you have an MS attack despite taking a medicine, we should talk about that.
Number two, if you have new MRI lesions despite taking a medicine, we should discuss that.
Number three, if your neurological examination is getting worse despite taking a medicine, that’s cause to discuss.
Number four, if you no longer tolerate the therapy, we need to discuss the switch.
And number five. If the medicine is no longer deemed safe, we’re going to talk about making a change.
